CompanyGraph
Zhongsheng Group Holdings Limited
0881 · HKEX · China
Price data from its 5Z0 listing on FSX, quoted in EUR
zs-group.com.cnFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 7 incoming connections
- ScaleRevenue is $24.39B, higher than 95% of all stocks globally
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
27.72BHKD3.53B · vs all stocks (USD)
Revenue (TTM)
191.33BHKD24.39B · vs all stocks (USD)
Profit Margin
-1.02%Beta
0.8930xvs all stocks
52-Week Change
-70.65%vs all stocks
Market Capitalization
27.72BHKD3.53B · vs all stocks (USD)
Enterprise Value
34.35BHKD4.38B · vs all stocks (USD)
Forward P/E
3.37xPrice to Sales (TTM)
0.0633xPrice to Book (MRQ)
0.2047xEnterprise to Revenue
0.1800xEnterprise to EBITDA
13.51xProfit Margin
-1.02%Operating Margin
-1.43%Return on Assets (TTM)
0.20%Return on Equity (TTM)
-4.20%Revenue (TTM)
191.33BHKD24.39B · vs all stocks (USD)
Revenue per Share (TTM)
69.46HKDUpdated Aug 19, 2026Quarterly Revenue Growth
1.60%Gross Profit (TTM)
10.29BHKD1.31B · vs all stocks (USD)
EBITDA (TTM)
2.36BHKD301.21M · vs all stocks (USD)
Net Income (TTM)
-1.95BHKD-248.27M · vs all stocks (USD)
Operating Cash Flow (TTM)
10.95BHKD1.40B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.16BHKD402.89M · vs all stocks (USD)
5-Year Average Dividend Yield
4.92%vs all stocks
Payout Ratio
55.57%Minority Interest (Equity)
-142.73MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.7100CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.7100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
2.37BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.37BSharesFY2025 · Dec 31, 2025Operating Cash Flow
1.21BCNYFY2025 · Dec 31, 2025Free Cash Flow
-1.04BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
15.42BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-2.06BCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.04BCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.68BCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
546.56MCNYFY2025 · Dec 31, 2025Capital Expenditures
-2.25BCNYFY2025 · Dec 31, 2025Net Intangibles (CF)
-52.11MCNYFY2025 · Dec 31, 2025Net Acquisitions
-96.04MCNYFY2025 · Dec 31, 2025Purchase of Investments
-212.50MCNYFY2025 · Dec 31, 2025Sale of Investments
73.15MCNYFY2025 · Dec 31, 2025Other Investing Activity
3.19MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.48BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
94.71BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-100.16BCNYFY2025 · Dec 31, 2025Common Stock Repurchase
0.00CNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.47BCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.20BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-8.12BCNYFY2025 · Dec 31, 2025Shares Outstanding
2.37BSharesUpdated Aug 19, 2026Float Shares
858.91MSharesUpdated Aug 19, 2026% Held by Insiders
63.71%vs all stocks
% Held by Institutions
20.76%vs all stocks
Total Cash (MRQ)
18.19BHKD2.32B · vs all stocks (USD)
Total Cash per Share (MRQ)
6.60HKDUpdated Aug 19, 2026Total Debt (MRQ)
40.33BHKD5.14B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.7962xCurrent Ratio (MRQ)
1.56xBook Value per Share (MRQ)
21.47HKDUpdated Aug 19, 2026Total Assets
103.72BCNY15.38B · vs all stocks (USD)
Total Current Assets
61.30BCNYFY2025 · Dec 31, 2025Total Liabilities
60.19BCNYFY2025 · Dec 31, 2025Total Non-current Assets
42.42BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
21.03BCNYFY2025 · Dec 31, 2025Total Current Liabilities
39.16BCNYFY2025 · Dec 31, 2025Cash
12.15BCNYFY2025 · Dec 31, 2025Cash Equivalents
3.35BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
15.50BCNYFY2025 · Dec 31, 2025Other Short-term Investments
125.79MCNYFY2025 · Dec 31, 2025Accounts Receivable
2.96BCNYFY2025 · Dec 31, 2025Inventory
17.93BCNYFY2025 · Dec 31, 2025Accounts Payable
16.54BCNYFY2025 · Dec 31, 2025Short-term Debt
16.67BCNYFY2025 · Dec 31, 2025Other Current Liabilities
26.32MCNYFY2025 · Dec 31, 2025Long-term Debt
17.99BCNYFY2025 · Dec 31, 2025Common Stock (Book)
207.00KCNYFY2025 · Dec 31, 2025Retained Earnings
42.12BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
43.53BCNY6.46B · vs all stocks (USD)
Treasury Stock
193.65MCNYFY2025 · Dec 31, 202552-Week Low
4.12HKDUpdated Aug 19, 202652-Week High
18.73HKDUpdated Aug 19, 202652-Week Change
-70.65%vs all stocks
Beta
0.8930xvs all stocks
50-Day MA
4.91HKDUpdated Aug 19, 2026200-Day MA
8.74HKDUpdated Aug 19, 2026Avg 10-Day Volume
6.58MSharesUpdated Aug 19, 2026Avg 30-Day Volume
7.11MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.8300HKDUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 5 outgoing, 7 incoming connectionsNotable
Outgoing: 5.00Incoming: 7.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Revenue is $24.39B, higher than 95% of all stocks globallySignificant
Revenue (USD): 24,392,588,143.242Global P95: 14,667,937,174.886
Market cap is $3.53B, above the global median of $1.15BNotable
Market cap (USD): 3,533,703,838.761Global Median: 1,146,734,693.424
Levered free cash flow is $402.89M, above the global median of $16.24MNotable
Levered free cash flow (USD): 402,889,749.858Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Cosmos Pharmaceutical Corp.
Tier 1FlowUnit ReplicationProductionInterface
Sumber Alfaria Trijaya Tbk
Tier 1FlowUnit ReplicationInterfaceProduction
Group 1 Automotive Inc.
Tier 1FlowUnit ReplicationInterfaceRisk
Aldrees Petroleum and Transport Services Company
Tier 1FlowUnit ReplicationInterfaceProduction
Inchcape plc
Tier 1FlowUnit ReplicationInterfaceRisk
Sonic Automotive Inc.
Tier 1FlowUnit ReplicationInterfaceRisk
Xiamen C&D Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Ollie's Bargain Outlet Holdings Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Bright Horizons Family Solutions Inc.
Tier 1FlowUnit ReplicationInterfaceSenseMaking
Dashenlin Pharmaceutical Group Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRule